Clene Inc. (CLNN) CEO receives 75,000 options at $5.42 exercise price

Rhea-AI Filing Summary

Clene Inc. reported an insider equity award for President and CEO Robert Dee Etherington, who is also a director. On January 22, 2026, he received a stock option for 75,000 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The footnote explains that these options vest immediately upon grant and are exercisable until January 21, 2036. Following this grant, Etherington directly holds 75,000 derivative securities in the form of these stock options.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Etherington Robert Dee

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$5.42	01/22/2026		A		75,000		(1)	01/21/2036	common stock	75,000	$0	75,000	D

Explanation of Responses:

1. This option was granted on January 22, 2026 as an option for 75,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in this Clene Inc. (CLNN) Form 4 filing?

The insider is Robert Dee Etherington, who serves as President, CEO, and a director of Clene Inc..

What type of securities did Robert Dee Etherington receive from Clene Inc. (CLNN)?

He received a stock option covering 75,000 shares of Clene Inc. common stock under the company’s Amended 2020 Stock Plan.

What is the exercise price of the stock options granted to the Clene Inc. (CLNN) CEO?

The stock options have an exercise price of $5.42 per share, as disclosed in the filing and related footnote.

When do the stock options granted to the Clene Inc. (CLNN) CEO vest?

According to the footnote, the options vest immediately upon grant, meaning they were fully vested on January 22, 2026.

When do the stock options granted to the Clene Inc. (CLNN) CEO expire?

The options are exercisable until January 21, 2036, which is the expiration date listed for this derivative security.

Does Robert Dee Etherington hold the Clene Inc. (CLNN) options directly or indirectly?

The filing shows that the 75,000 stock options are held with direct (D) ownership by Robert Dee Etherington.

How many derivative securities does the Clene Inc. (CLNN) CEO own after this transaction?

After this grant, the Form 4 reports that Robert Dee Etherington beneficially owns 75,000 derivative securities in the form of these stock options.